glp-1/gip agonists Schematic illustration of monoagonists, dual and triple New Weight-Loss Drugs Are Poised
Description
Whether youre just beginning your weight loss journey or looking to boost your results, GLP-1 therapy could be the missing link
So far, the co-agonist drugs which have reached phase 2 trials have demonstrated an improved glycaemic profile with chronic administration
[Google Scholar] 37.Silva AC, et al
Honigberg MC, Chang LS, McGuire DK, Plutzky J, Aroda VR, Vaduganathan M
